Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN) a randomised, open-label, phase 2 trial

Yue, DS; Xu, SD; Wang, Q; Li, XF; Shen, Y; Zhao, H; Chen, C; Mao, WM; Liu, W; Liu, JF; Zhang, LJ; Ma, HT; Li, Q; Yang, Y; Liu, YY; Chen, HQ; Wang, CL

Wang, CL (reprint author), Tianjin Med Univ Canc Inst & Hosp, Dept Lung Canc, Lung Canc Ctr, Key Lab Canc Prevent & Therapy,Natl Clin Res Ctr, Huan Hu Xi Rd,Ti Yuan Bei, Tianjin 300060, Peoples R China.

LANCET RESPIRATORY MEDICINE, 2018; 6 (11): 863

Abstract

Background Adjuvant chemotherapy after radical resection of stage IIIA non-small-cell lung cancer (NSCLC) has quite poor outcomes. We aimed to investi......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索